Nuclear Medicine and Radiopharmaceuticals Market Report

Global and China Nuclear Medicine and Radiopharmaceuticals Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 06, 2022
  • PAGES：170
  • REPORT CODE：GMM1350659
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Nuclear Medicine and Radiopharmaceuticals industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Bracco Imaging

    • Lantheus

    • GE Healthcare

    • Eli Lilly

    • SIEMENS

    • Triad Isotopes

    • Mallinckrodt

    • Nordion

    • Dongcheng

    • Bayer

    • IBA Group

    • Advanced Accelerator Applications

    • Navidea

    • China Isotope & Radiation

    • Jubilant Pharma

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Diagnostic Radioisotopes

    • Therapeutic Radioisotopes

    Application:

    • Oncology

    • Cardiology

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Nuclear Medicine and Radiopharmaceuticals Industry Overview

      • 1.1.1 Nuclear Medicine and Radiopharmaceuticals Market Scope and Market Segments

      • 1.1.2 Nuclear Medicine and Radiopharmaceuticals Industry Characteristics

      • 1.1.3 Global and China Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Nuclear Medicine and Radiopharmaceuticals Production Value and Growth Rate (2017-2028)

    • 1.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Diagnostic Radioisotopes

      • 1.2.2 Therapeutic Radioisotopes

    • 1.3 Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Oncology

      • 1.3.2 Cardiology

      • 1.3.3 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Nuclear Medicine and Radiopharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Nuclear Medicine and Radiopharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Nuclear Medicine and Radiopharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Nuclear Medicine and Radiopharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Nuclear Medicine and Radiopharmaceuticals Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Nuclear Medicine and Radiopharmaceuticals Industry Porter's Five Forces Model Analysis

      • 2.2.3 Nuclear Medicine and Radiopharmaceuticals Industry PEST Analysis

    • 2.3 Nuclear Medicine and Radiopharmaceuticals Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Nuclear Medicine and Radiopharmaceuticals Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Nuclear Medicine and Radiopharmaceuticals Industry

    Chapter 3 Global and China Nuclear Medicine and Radiopharmaceuticals Market, by Manufacturer

    • 3.1 Global and China Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Nuclear Medicine and Radiopharmaceuticals Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Nuclear Medicine and Radiopharmaceuticals Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Nuclear Medicine and Radiopharmaceuticals Market Top 3 Players

    Chapter 4 Global and China Nuclear Medicine and Radiopharmaceuticals Market, by Type (2017-2028)

    • 4.1 Nuclear Medicine and Radiopharmaceuticals Market Trend, by Type

    • 4.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Nuclear Medicine and Radiopharmaceuticals Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Nuclear Medicine and Radiopharmaceuticals Price Trend, by Type (2017-2028)

    • 4.3 China Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Nuclear Medicine and Radiopharmaceuticals Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Nuclear Medicine and Radiopharmaceuticals Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Nuclear Medicine and Radiopharmaceuticals Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Nuclear Medicine and Radiopharmaceuticals Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Nuclear Medicine and Radiopharmaceuticals Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Nuclear Medicine and Radiopharmaceuticals Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Nuclear Medicine and Radiopharmaceuticals Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Nuclear Medicine and Radiopharmaceuticals Market Analysis

    • 7.1 North America Nuclear Medicine and Radiopharmaceuticals Market, by Type

    • 7.2 North America Nuclear Medicine and Radiopharmaceuticals Market, by Application

    • 7.3 North America Nuclear Medicine and Radiopharmaceuticals Market Analysis and Forecast, by Country

      • 7.3.1 United States Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Nuclear Medicine and Radiopharmaceuticals Market Analysis

    • 8.1 Europe Nuclear Medicine and Radiopharmaceuticals Market, by Type

    • 8.2 Europe Nuclear Medicine and Radiopharmaceuticals Market, by Application

    • 8.3 Europe Nuclear Medicine and Radiopharmaceuticals Market Analysis and Forecast, by Country

      • 8.3.1 Germany Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Nuclear Medicine and Radiopharmaceuticals Market Analysis

    • 9.1 APAC Nuclear Medicine and Radiopharmaceuticals Market, by Type

    • 9.2 APAC Nuclear Medicine and Radiopharmaceuticals Market, by Application

    • 9.3 APAC Nuclear Medicine and Radiopharmaceuticals Market Analysis and Forecast, by Country

      • 9.3.1 China Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Analysis

    • 10.1 Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market, by Type

    • 10.2 Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market, by Application

    • 10.3 Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Nuclear Medicine and Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Nuclear Medicine and Radiopharmaceuticals Company Profiles

      • 11.1 Bracco Imaging

        • 11.1.1 Bracco Imaging Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.1.3 Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Lantheus

        • 11.2.1 Lantheus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Lantheus Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.2.3 Lantheus Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 GE Healthcare

        • 11.3.1 GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 GE Healthcare Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.3.3 GE Healthcare Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Eli Lilly

        • 11.4.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Eli Lilly Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.4.3 Eli Lilly Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 SIEMENS

        • 11.5.1 SIEMENS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 SIEMENS Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.5.3 SIEMENS Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Triad Isotopes

        • 11.6.1 Triad Isotopes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Triad Isotopes Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.6.3 Triad Isotopes Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Mallinckrodt

        • 11.7.1 Mallinckrodt Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Mallinckrodt Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.7.3 Mallinckrodt Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Nordion

        • 11.8.1 Nordion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Nordion Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.8.3 Nordion Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Dongcheng

        • 11.9.1 Dongcheng Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Dongcheng Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.9.3 Dongcheng Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Bayer

        • 11.10.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Bayer Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.10.3 Bayer Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 IBA Group

        • 11.11.1 IBA Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 IBA Group Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.11.3 IBA Group Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Advanced Accelerator Applications

        • 11.12.1 Advanced Accelerator Applications Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Advanced Accelerator Applications Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.12.3 Advanced Accelerator Applications Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Navidea

        • 11.13.1 Navidea Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Navidea Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.13.3 Navidea Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 China Isotope & Radiation

        • 11.14.1 China Isotope & Radiation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 China Isotope & Radiation Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.14.3 China Isotope & Radiation Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Jubilant Pharma

        • 11.15.1 Jubilant Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.15.3 Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Nuclear Medicine and Radiopharmaceuticals Industry Investment Prospect and Risk Assessment

    • 12.1 Nuclear Medicine and Radiopharmaceuticals Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Nuclear Medicine and Radiopharmaceuticals Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure China Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Production Value and Growth Rate (2017-2028)

    • Figure China Nuclear Medicine and Radiopharmaceuticals Production Value and Growth Rate (2017-2028)

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Radioisotopes (2017-2028)

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Radioisotopes (2017-2028)

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Oncology (2017-2028)

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Cardiology (2017-2028)

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Nuclear Medicine and Radiopharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Nuclear Medicine and Radiopharmaceuticals Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Nuclear Medicine and Radiopharmaceuticals Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Nuclear Medicine and Radiopharmaceuticals Market Share, by Manufacturer in 2021

    • Figure Global and China Nuclear Medicine and Radiopharmaceuticals Market Share, by Manufacturer in 2022

    • Table Global Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Global Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Global Nuclear Medicine and Radiopharmaceuticals Sales Value, by Type (2017-2028)

    • Table Global Nuclear Medicine and Radiopharmaceuticals Sales Value Share, by Type (2017-2028)

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Price Trend, by Type (2017-2028)

    • Table China Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table China Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure China Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table China Nuclear Medicine and Radiopharmaceuticals Sales Value, by Type (2017-2028)

    • Table China Nuclear Medicine and Radiopharmaceuticals Sales Value Share, by Type (2017-2028)

    • Figure China Nuclear Medicine and Radiopharmaceuticals Price Trend, by Type (2017-2028)

    • Table Global Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Global Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Table Global Nuclear Medicine and Radiopharmaceuticals Sales Value, by Application (2017-2028)

    • Table Global Nuclear Medicine and Radiopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Table China Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table China Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure China Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Table China Nuclear Medicine and Radiopharmaceuticals Sales Value, by Application (2017-2028)

    • Table China Nuclear Medicine and Radiopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure China Nuclear Medicine and Radiopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure China Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure North America Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Table North America Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table North America Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure North America Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table North America Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table North America Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure North America Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure United States Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure United States Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Canada Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Europe Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Europe Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Europe Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Europe Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Europe Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Europe Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Germany Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure UK Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure UK Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure France Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure France Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Italy Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Spain Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Poland Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Russia Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table APAC Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table APAC Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure APAC Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table APAC Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table APAC Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure APAC Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure China Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure China Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Japan Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure India Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure India Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Nuclear Medicine and Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Nuclear Medicine and Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Bracco Imaging Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bracco Imaging Product Profiles, Application and Specification

    • Table Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Lantheus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lantheus Product Profiles, Application and Specification

    • Table Lantheus Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GE Healthcare Product Profiles, Application and Specification

    • Table GE Healthcare Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table SIEMENS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table SIEMENS Product Profiles, Application and Specification

    • Table SIEMENS Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Triad Isotopes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Triad Isotopes Product Profiles, Application and Specification

    • Table Triad Isotopes Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mallinckrodt Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mallinckrodt Product Profiles, Application and Specification

    • Table Mallinckrodt Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nordion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nordion Product Profiles, Application and Specification

    • Table Nordion Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dongcheng Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dongcheng Product Profiles, Application and Specification

    • Table Dongcheng Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Product Profiles, Application and Specification

    • Table Bayer Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table IBA Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table IBA Group Product Profiles, Application and Specification

    • Table IBA Group Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Advanced Accelerator Applications Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Advanced Accelerator Applications Product Profiles, Application and Specification

    • Table Advanced Accelerator Applications Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Navidea Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Navidea Product Profiles, Application and Specification

    • Table Navidea Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table China Isotope & Radiation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table China Isotope & Radiation Product Profiles, Application and Specification

    • Table China Isotope & Radiation Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Jubilant Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Jubilant Pharma Product Profiles, Application and Specification

    • Table Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US